-
1
-
-
22144474043
-
Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents
-
DOI 10.1161/CIRCULATIONAHA.104.508937
-
Finn AV, Kolodgie FD, Harnek J, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus-or paclitaxel-eluting stents. Circulation 2005;112:270-8. (Pubitemid 40982311)
-
(2005)
Circulation
, vol.112
, Issue.2
, pp. 270-278
-
-
Finn, A.V.1
Kolodgie, F.D.2
Harnek, J.3
Guerrero, L.J.4
Acampado, E.5
Tefera, K.6
Skorija, K.7
Weber, D.K.8
Gold, H.K.9
Virmani, R.10
-
2
-
-
21044454746
-
Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery
-
DOI 10.1016/j.jacc.2005.01.049, PII S0735109705004833
-
Tsagalou E, Chieffo A, Iakovou I, et al. Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery. J Am Coll Cardiol 2005;45:1570-3. (Pubitemid 40704487)
-
(2005)
Journal of the American College of Cardiology
, vol.45
, Issue.10
, pp. 1570-1573
-
-
Tsagalou, E.1
Chieffo, A.2
Iakovou, I.3
Ge, L.4
Sangiorgi, G.M.5
Corvaja, N.6
Airoldi, F.7
Montorfano, M.8
Michev, I.9
Colombo, A.10
-
3
-
-
33646045590
-
Impact of overlapping drug-eluting stents in patients undergoing percutaneous coronary intervention
-
Chu WW, Kuchulakanti PK, Torguson R, et al. Impact of overlapping drug-eluting stents in patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv 2006;67:595-9.
-
(2006)
Catheter Cardiovasc Interv
, vol.67
, pp. 595-599
-
-
Chu, W.W.1
Kuchulakanti, P.K.2
Torguson, R.3
-
4
-
-
80052165059
-
Long-term clinical outcomes of overlapping heterogeneous drug-eluting stents compared with homogeneous drug-eluting stents
-
Her SH, Yoo KD, Park CS, et al. Long-term clinical outcomes of overlapping heterogeneous drug-eluting stents compared with homogeneous drug-eluting stents. Heart 2011;97:1501-6.
-
(2011)
Heart
, vol.97
, pp. 1501-1506
-
-
Her, S.H.1
Yoo, K.D.2
Park, C.S.3
-
5
-
-
77949283671
-
Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation
-
Raber L, Juni P, Loffel L, et al. Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation. J Am Coll Cardiol 2010;55:1178-88.
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 1178-1188
-
-
Raber, L.1
Juni, P.2
Loffel, L.3
-
6
-
-
77954746572
-
Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents
-
Guagliumi G, Musumeci G, Sirbu V, et al. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents. JACC Cardiovasc Interv 2010;3:531-9.
-
(2010)
JACC Cardiovasc Interv
, vol.3
, pp. 531-539
-
-
Guagliumi, G.1
Musumeci, G.2
Sirbu, V.3
-
7
-
-
79960601139
-
Impact of drug release kinetics on vascular response to different zotarolimus-eluting stents implanted in patients with long coronary stenoses: The LongOCT study (Optical Coherence Tomography in Long Lesions)
-
Guagliumi G, Ikejima H, Sirbu V, et al. Impact of drug release kinetics on vascular response to different zotarolimus-eluting stents implanted in patients with long coronary stenoses: the LongOCT study (Optical Coherence Tomography in Long Lesions). JACC Cardiovasc Interv 2011;4:778-85.
-
(2011)
JACC Cardiovasc Interv
, vol.4
, pp. 778-785
-
-
Guagliumi, G.1
Ikejima, H.2
Sirbu, V.3
-
8
-
-
84876117460
-
TCT-33 Intracoronary Optical Coherence Tomography and Histology of Overlapping Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model: The Potential Implications for Clinical Practice
-
In Press
-
Farooq V, Heo HJ, Gogas B, et al. TCT-33 Intracoronary Optical Coherence Tomography and Histology of Overlapping Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model: The Potential Implications for Clinical Practice. JACC Interventions (In Press).
-
JACC Interventions
-
-
Farooq, V.1
Heo, H.J.2
Gogas, B.3
-
9
-
-
0037303940
-
Drug eluting stents: Are human and animal studies comparable?
-
Virmani R, Kolodgie FD, Farb A, et al. Drug eluting stents: are human and animal studies comparable? Heart 2003;89:133-8. (Pubitemid 36115090)
-
(2003)
Heart
, vol.89
, Issue.2
, pp. 133-138
-
-
Virmani, R.1
Kolodgie, F.D.2
Farb, A.3
Lafont, A.4
-
10
-
-
84858309763
-
One-year outcomes of patients with the zotarolimus-eluting coronary stent: RESOLUTE International Registry
-
Neumann FJ, Widimsky P, Belardi JA. One-year outcomes of patients with the zotarolimus-eluting coronary stent: RESOLUTE International Registry. EuroIntervention 2012;7:1181-8.
-
(2012)
EuroIntervention
, vol.7
, pp. 1181-1188
-
-
Neumann, F.J.1
Widimsky, P.2
Belardi, J.A.3
-
11
-
-
79953735235
-
Unrestricted randomised use of two new generation drug-eluting coronary stents:2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial
-
Silber S, Windecker S, Vranckx P, et al. Unrestricted randomised use of two new generation drug-eluting coronary stents:2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial. Lancet 2011;377:1241-7.
-
(2011)
Lancet
, vol.377
, pp. 1241-1247
-
-
Silber, S.1
Windecker, S.2
Vranckx, P.3
-
12
-
-
79955056445
-
Clinical evaluation of the Resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries: The RESOLUTE US clinical trial
-
Yeung AC, Leon MB, Jain A, et al. Clinical evaluation of the Resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries: the RESOLUTE US clinical trial. J Am Coll Cardiol 2011;57:1778-83.
-
(2011)
J Am Coll Cardiol
, vol.57
, pp. 1778-1783
-
-
Yeung, A.C.1
Leon, M.B.2
Jain, A.3
-
13
-
-
70350020760
-
Clinical and angiographic results with the next-generation resolute stent system: A prospective, multicenter, first-in-human trial
-
Meredith IT, Worthley S, Whitbourn R, et al. Clinical and angiographic results with the next-generation resolute stent system: a prospective, multicenter, first-in-human trial. JACC Cardiovasc Interv 2009;2:977-85.
-
(2009)
JACC Cardiovasc Interv
, vol.2
, pp. 977-985
-
-
Meredith, I.T.1
Worthley, S.2
Whitbourn, R.3
-
15
-
-
77954392890
-
Comparison of zotarolimus-eluting and everolimus-eluting coronary stents
-
Serruys PW, Silber S, Garg S, et al. Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. N Engl J Med 2010;363:136-46.
-
(2010)
N Engl J Med
, vol.363
, pp. 136-146
-
-
Serruys, P.W.1
Silber, S.2
Garg, S.3
-
16
-
-
84872086285
-
Clinical endpoint adjudication in a contemporary all-comers coronary stent investigation: Methodology and external validation
-
Vranckx P, McFadden E, Cutlip DE, et al. Clinical endpoint adjudication in a contemporary all-comers coronary stent investigation: methodology and external validation. Contemp Clin Trials 2012;8:368-74.
-
(2012)
Contemp Clin Trials
, vol.8
, pp. 368-374
-
-
Vranckx, P.1
McFadden, E.2
Cutlip, D.E.3
-
17
-
-
84872086285
-
Clinical event committees in coronary stent trials: Insights and recommendations based on experience in an unselected study population
-
Vranckx P, McFadden E, Mehran R, et al. Clinical event committees in coronary stent trials: insights and recommendations based on experience in an unselected study population. EuroIntervention 2012;8:368-74.
-
(2012)
EuroIntervention
, vol.8
, pp. 368-374
-
-
Vranckx, P.1
McFadden, E.2
Mehran, R.3
-
18
-
-
79955073346
-
Rationale and design of the clinical evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the treatment of de novo lesions in native coronary arteries (the RESOLUTE US clinical trial)
-
Mauri L, Leon MB, Yeung AC, et al. Rationale and design of the clinical evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the treatment of de novo lesions in native coronary arteries (the RESOLUTE US clinical trial). Am Heart J 2011;161:807-14.
-
(2011)
Am Heart J
, vol.161
, pp. 807-814
-
-
Mauri, L.1
Leon, M.B.2
Yeung, A.C.3
-
19
-
-
84866057851
-
Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: Impact on outcome reporting
-
Vranckx P, Farooq V, Garg S, et al. Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting. Heart 2012;98:1424-30.
-
(2012)
Heart
, vol.98
, pp. 1424-1430
-
-
Vranckx, P.1
Farooq, V.2
Garg, S.3
-
20
-
-
77954399153
-
Myocardial infarction adjudication in contemporary all-comer stent trials: Balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies
-
Vranckx P, Cutlip DE, Mehran R, et al. Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies. EuroIntervention 2010;5:871-4.
-
(2010)
EuroIntervention
, vol.5
, pp. 871-874
-
-
Vranckx, P.1
Cutlip, D.E.2
Mehran, R.3
-
21
-
-
34247558672
-
Clinical end points in coronary stent trials: A case for standardized definitions
-
DOI 10.1161/CIRCULATIONAHA.106.685313, PII 0000301720070501000016
-
Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-51. (Pubitemid 46685903)
-
(2007)
Circulation
, vol.115
, Issue.17
, pp. 2344-2351
-
-
Cutlip, D.E.1
Windecker, S.2
Mehran, R.3
Boam, A.4
Cohen, D.J.5
Van Es, G.-A.6
Steg, P.G.7
Morel, M.-A.8
Mauri, L.9
Vranckx, P.10
McFadden, E.11
Lansky, A.12
Hamon, M.13
Krucoff, M.W.14
Serruys, P.W.15
-
23
-
-
29344457180
-
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention)
-
Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006;47:e1-21.
-
(2006)
J Am Coll Cardiol
, vol.47
-
-
Smith Jr., S.C.1
Feldman, T.E.2
Hirshfeld Jr., J.W.3
-
24
-
-
33644775142
-
Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: Support for the use of drug-eluting stents in contemporary clinical practice
-
DOI 10.1161/CIRCULATIONAHA.105.552190, PII 0000301720051122000016
-
Dawkins KD, Grube E, Guagliumi G, et al. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation 2005;112:3306-13. (Pubitemid 43739376)
-
(2005)
Circulation
, vol.112
, Issue.21
, pp. 3306-3313
-
-
Dawkins, K.D.1
Grube, E.2
Guagliumi, G.3
Banning, A.P.4
Zmudka, K.5
Colombo, A.6
Thuesen, L.7
Hauptman, K.8
Marco, J.9
Wijns, W.10
Popma, J.J.11
Koglin, J.12
Russell, M.E.13
-
25
-
-
24644477492
-
Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: A randomized controlled trial
-
DOI 10.1001/jama.294.10.1215
-
Stone GW, Ellis SG, Cannon L, et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 2005;294:1215-23. (Pubitemid 41352109)
-
(2005)
Journal of the American Medical Association
, vol.294
, Issue.10
, pp. 1215-1223
-
-
Stone, G.W.1
Ellis, S.G.2
Cannon, L.3
Mann, J.T.4
Greenberg, J.D.5
Spriggs, D.6
O'Shaughnessy, C.D.7
DeMaio, S.8
Hall, P.9
Popma, J.J.10
Koglin, J.11
Russell, M.E.12
-
26
-
-
77949290735
-
Safety and efficacy of multiple, overlapping polymer-based paclitaxel-eluting stents
-
Dawkins KD Grube E, Guagliumi G, et al. Safety and efficacy of multiple, overlapping polymer-based paclitaxel-eluting stents. EuroIntervention 2007;3:213-21.
-
(2007)
EuroIntervention
, vol.3
, pp. 213-221
-
-
Dawkins, K.D.1
Grube, E.2
Guagliumi, G.3
-
27
-
-
64849085105
-
Use of multiple overlapping sirolimus-eluting stents for treatment of long coronary artery lesions: Results from a single-center registry in 318 consecutive patients
-
Ruchin PE, Trabattoni D, Fabbiocchi F, et al. Use of multiple overlapping sirolimus-eluting stents for treatment of long coronary artery lesions: results from a single-center registry in 318 consecutive patients. Int J Cardiol 2009;134:231-7.
-
(2009)
Int J Cardiol
, vol.134
, pp. 231-237
-
-
Ruchin, P.E.1
Trabattoni, D.2
Fabbiocchi, F.3
-
28
-
-
34250835092
-
Vascular responses to drug eluting stents: Importance of delayed healing
-
DOI 10.1161/ATVBAHA.107.144220, PII 0004360520070700000003
-
Finn AV, Nakazawa G, Joner M, et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 2007;27:1500-10. (Pubitemid 46986103)
-
(2007)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.27
, Issue.7
, pp. 1500-1510
-
-
Finn, A.V.1
Nakazawa, G.2
Joner, M.3
Kolodgie, F.D.4
Mont, E.K.5
Gold, H.K.6
Virmani, R.7
-
29
-
-
67651119696
-
Comparison of inflammatory response after implantation of sirolimus-and paclitaxel-eluting stents in porcine coronary arteries
-
1-2
-
Wilson GJ, Nakazawa G, Schwartz RS, et al. Comparison of inflammatory response after implantation of sirolimus-and paclitaxel-eluting stents in porcine coronary arteries. Circulation 2009;120:141-9, 1-2.
-
(2009)
Circulation
, vol.120
, pp. 141-149
-
-
Wilson, G.J.1
Nakazawa, G.2
Schwartz, R.S.3
-
30
-
-
74549129104
-
An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: A LEADERS trial sub-study
-
Barlis P, Regar E, Serruys PW, et al. An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study. Eur Heart J 2010;31:165-76.
-
(2010)
Eur Heart J
, vol.31
, pp. 165-176
-
-
Barlis, P.1
Regar, E.2
Serruys, P.W.3
-
31
-
-
73949122498
-
Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): A randomised trial
-
Kedhi E, Joesoef KS, McFadden E, et al. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial. Lancet 2010;375:201-9.
-
(2010)
Lancet
, vol.375
, pp. 201-209
-
-
Kedhi, E.1
Joesoef, K.S.2
McFadden, E.3
-
32
-
-
84861482050
-
Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: Comparison with sirolimus-eluting stent using optical coherence tomography
-
Choi HH, Kim JS, Yoon DH, et al. Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: comparison with sirolimus-eluting stent using optical coherence tomography. Int J Cardiovasc Imaging 2012;28:491-7.
-
(2012)
Int J Cardiovasc Imaging
, vol.28
, pp. 491-497
-
-
Choi, H.H.1
Kim, J.S.2
Yoon, D.H.3
-
33
-
-
80054071576
-
Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. A fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: An optical coherence tomography substudy from the RESOLUTE All Comers trial
-
Gutierrez-Chico JL, van Geuns RJ, Regar E, et al. Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial. Eur Heart J 2011;32:2454-63.
-
(2011)
Eur Heart J
, vol.32
, pp. 2454-2463
-
-
Gutierrez-Chico, J.L.1
Van Geuns, R.J.2
Regar, E.3
-
34
-
-
80051759292
-
Restenosis: Delineating the numerous causes of drug-eluting stent restenosis
-
Farooq V, Gogas BD, Serruys PW. Restenosis: delineating the numerous causes of drug-eluting stent restenosis. Circ Cardiovasc Interv 2011;4:195-205.
-
(2011)
Circ Cardiovasc Interv
, vol.4
, pp. 195-205
-
-
Farooq, V.1
Gogas, B.D.2
Serruys, P.W.3
-
37
-
-
70449556979
-
Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents:1-year results of the PAINT trial
-
Lemos PA, Moulin B, Perin MA, et al. Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents:1-year results of the PAINT trial. Catheter Cardiovasc Interv 2009;74:665-73.
-
(2009)
Catheter Cardiovasc Interv
, vol.74
, pp. 665-673
-
-
Lemos, P.A.1
Moulin, B.2
Perin, M.A.3
-
38
-
-
42049104505
-
The next-generation Endeavor Resolute stent:4-month clinical and angiographic results from the Endeavor Resolute first-in-man trial
-
Meredith IT, Worthley S, Whitbourn R, et al. The next-generation Endeavor Resolute stent:4-month clinical and angiographic results from the Endeavor Resolute first-in-man trial. EuroIntervention 2007;3:50-3.
-
(2007)
EuroIntervention
, vol.3
, pp. 50-53
-
-
Meredith, I.T.1
Worthley, S.2
Whitbourn, R.3
-
39
-
-
0035849543
-
Intracoronary stenting and angiographic results: Strut thickness effect on restenosis outcome (ISAR-STEREO) trial
-
Kastrati A, Mehilli J, Dirschinger J, et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation 2001;103:2816-21. (Pubitemid 32550070)
-
(2001)
Circulation
, vol.103
, Issue.23
, pp. 2816-2821
-
-
Kastrati, A.1
Mehilli, J.2
Dirschinger, J.3
Dotzer, F.4
Schuhlen, H.5
Neumann, F.-J.6
Fleckenstein, M.7
Pfafferott, C.8
Seyfarth, M.9
Schomig, A.10
-
40
-
-
0037392914
-
Intracoronary stenting and angiographic results: Strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial
-
DOI 10.1016/S0735-1097(03)00119-0
-
Pache J, Kastrati A, Mehilli J, et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol 2003;41:1283-8. (Pubitemid 36438988)
-
(2003)
Journal of the American College of Cardiology
, vol.41
, Issue.8
, pp. 1283-1288
-
-
Pache, J.1
Kastrati, A.2
Mehilli, J.3
Schuhlen, H.4
Dotzer, F.5
Hausleiter, J.6
Fleckenstein, M.7
Neuman, F.-J.8
Sattelberger, U.9
Schmitt, C.10
Muller, M.11
Dirschinger, J.12
Schomig, A.13
-
41
-
-
65249097748
-
Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: A report from the SCAAR (Swedish Angiography and Angioplasty Registry)
-
Frobert O, Lagerqvist B, Carlsson J, et al. Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry). J Am Coll Cardiol 2009;53:1660-7.
-
(2009)
J Am Coll Cardiol
, vol.53
, pp. 1660-1667
-
-
Frobert, O.1
Lagerqvist, B.2
Carlsson, J.3
-
42
-
-
84859345559
-
Role of endothelial shear stress in stent restenosis and thrombosis: Pathophysiologic mechanisms and implications for clinical translation
-
Koskinas KC, Chatzizisis YS, Antoniadis AP, et al. Role of endothelial shear stress in stent restenosis and thrombosis: pathophysiologic mechanisms and implications for clinical translation. J Am Coll Cardiol 2012;59:1337-49.
-
(2012)
J Am Coll Cardiol
, vol.59
, pp. 1337-1349
-
-
Koskinas, K.C.1
Chatzizisis, Y.S.2
Antoniadis, A.P.3
-
43
-
-
79952057270
-
Bioresorbable scaffold: The advent of a new era in percutaneous coronary and peripheral revascularization?
-
Onuma Y, Serruys PW. Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization? Circulation 2011;123:779-97.
-
(2011)
Circulation
, vol.123
, pp. 779-797
-
-
Onuma, Y.1
Serruys, P.W.2
-
44
-
-
84878529444
-
Bioresorbable scaffolds: Current knowledge, potentialities and limitations experienced during their first clinical applications
-
Jun. 28. Epub ahead of print
-
Bourantas CV, Onuma Y, Farooq V, et al. Bioresorbable scaffolds: current knowledge, potentialities and limitations experienced during their first clinical applications. Int J Cardiol 2012 Jun. 28. (Epub ahead of print).
-
(2012)
Int J Cardiol
-
-
Bourantas, C.V.1
Onuma, Y.2
Farooq, V.3
-
45
-
-
72249120556
-
Frequency and clinical consequences associated with sidebranch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting coronary stents
-
Popma JJ, Mauri L, O'Shaughnessy C, et al. Frequency and clinical consequences associated with sidebranch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting coronary stents. Circ Cardiovasc Interv 2009;2:133-9.
-
(2009)
Circ Cardiovasc Interv
, vol.2
, pp. 133-139
-
-
Popma, J.J.1
Mauri, L.2
O'Shaughnessy, C.3
-
46
-
-
79954538234
-
Side branch occlusion with everolimus-eluting and paclitaxel-eluting stents: Three-year results from the SPIRIT III randomised trial
-
Lansky AJ, Yaqub M, Hermiller JB, et al. Side branch occlusion with everolimus-eluting and paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial. EuroIntervention 2010;6(Suppl J):J44-52.
-
(2010)
EuroIntervention
, vol.6
, Issue.SUPPL. J
-
-
Lansky, A.J.1
Yaqub, M.2
Hermiller, J.B.3
-
47
-
-
84876103567
-
Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: An interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials
-
In press
-
Muramatsu T, Onuma Y, Garcia-Garcia HM, et al. Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: An interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials. JACC Interventions (In press).
-
JACC Interventions
-
-
Muramatsu, T.1
Onuma, Y.2
Garcia-Garcia, H.M.3
-
48
-
-
34247113737
-
Optimal medical therapy with or without PCI for stable coronary disease
-
DOI 10.1056/NEJMoa070829
-
Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356:1503-16. (Pubitemid 46588415)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.15
, pp. 1503-1516
-
-
Boden, W.E.1
O'Rourke, R.A.2
Teo, K.K.3
Hartigan, P.M.4
Maron, D.J.5
Kostuk, W.J.6
Knudtson, M.7
Dada, M.8
Casperson, P.9
Harris, C.L.10
Chaitman, B.R.11
Shaw, L.12
Gosselin, G.13
Nawaz, S.14
Title, L.M.15
Gau, G.16
Blaustein, A.S.17
Booth, D.C.18
Bates, E.R.19
Spertus, J.A.20
Berman, D.S.21
Mancini, G.B.J.22
Weintraub, W.S.23
more..
-
49
-
-
58349112528
-
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention
-
Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360:213-24.
-
(2009)
N Engl J Med
, vol.360
, pp. 213-224
-
-
Tonino, P.A.1
De Bruyne, B.2
Pijls, N.H.3
|